Founded in 1995, Jiangsu Hansoh Pharmaceutical Group Co., Ltd. is an innovation-driven pharmaceutical company integrating the R&D, manufacturing, and sales of drugs. As a principal subsidiary of Hansoh Pharma (03692.HK), the Company is committed to improving human health through continuous innovation, particularly in the treatment of major diseases including the areas of oncology, infections, the central nervous system, metabolic disorders, and autoimmune disease.
Hansoh Pharma, a leading innovation-driven pharmaceutical company in the PRC, is committed to improving human health through unremitting innovation, focusing mainly on such areas as anti-tumor, anti-infectives, CNS diseases, metabolic diseases, autoimmune diseases.
After more than 20 years of continuous investment in R&D, Jiangsu Hansoh Pharma has marketed 7 innovative drugs and has over 30 innovative drug programs in different clinical stages with over 50 clinical trials in progress, forming a rich pipeline.
Hansoh Pharma has always maintained dynamic consistency with global advanced access levels by continuously designing and building production facilities and production lines in accordance with international advanced standards and by using advanced production equipment.
Under the new normal in the pharmaceutical industry, Jiangsu Hansoh Pharma endeavors to be proactive in the implementation of national policies and the innovation of business structure.
Find the latest and most complete information about Hansoh Pharma!
Jiangsu Hansoh Pharma always adheres to the core values of responsibility, integrity, diligence, and innovation, serving human health with scientific and technological innovation, and assuming corporate social responsibility with accountable behavior in conducting business.
We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
Source: Xinhua News Agency
